Please login to the form below

Not currently logged in
Email:
Password:

Gregory Gallo joins Treato as chief commercial officer

Brings experience from Quest Diagnostics and Johnson & Johnson

Treato Gregory GalloIsrael-based Treato has appointed Gregory Gallo as its new chief commercial officer.

Working out of the online healthcare consumer insights firm's Princeton, New Jersey office, Gallo will be responsible for leading its business solutions unit as well as expanding the firm's global presence in the pharmaceutical industry.

Ido Hadari, Treato's chief executive officer, said: “Greg has a remarkable track record in helping build, lead and scale innovative businesses.

“We are excited to have Greg join our leadership team and look forward to benefitting from his vast knowledge and commercial experience in the healthcare data and analytics field.”

Gallo has over 20 years of commercial experience in the healthcare and pharmaceutical industries, having held senior roles at IntelliSante, ImpactRX, Johnson & Johnson and Quest Diagnostics.

He joins Treato from Activate Networks, now a part of Decision Resources Group, where he served as chief commercial officer and oversaw its commercial operations and growth.

12th February 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics